In this institution all patients with clinically significant blood culture isolates are routinely reviewed by members of the clinical microbiology team. After clinical assessment, further investigations and management are advised in consultation with the primary care team responsible for the patient. This form of laboratory-ward liaison is a well established practice but has rarely been audited. The clinical impact of laboratory data has been questioned, particularly when broad spectrum empirical antimicrobial treatment is available. ' We undertook a prospective analysis of our blood culture reporting protocol with particular reference to our hospital antibiotic policy. This policy gives guidance on empiric antibiotic treatment in light of the probable source of infection. The policy is produced under the guidance of the consultant clinical microbiologist, with contributions on individual categories of infection from relevant clinicians. It is approved by each clinical consultant before distribution to all non-consultant hospital doctors. Educational follow up is given at induction days for new interns and at medical and surgical grand rounds. This study was undertaken just before the biannual update of the policy.
Audit of routine laboratory and clinical practice has become increasingly important. Critical assessment of these practices may reveal areas of deficiency and thus lead to improvement in the delivery of service. Validation of the clinical impact of such practices gives a useful educational and bargaining tool when dealing with fellow clinicians and management.
In this institution all patients with clinically significant blood culture isolates are routinely reviewed by members of the clinical microbiology team. After clinical assessment, further investigations and management are advised in consultation with the primary care team responsible for the patient. This form of laboratory-ward liaison is a well established practice but has rarely been audited. The clinical impact of laboratory data has been questioned, particularly when broad spectrum empirical antimicrobial treatment is available. ' We undertook a prospective analysis of our blood culture reporting protocol with particular reference to our hospital antibiotic policy. This policy gives guidance on empiric antibiotic treatment in light of (table 2) . Empiric treatment was started at the time the blood culture was taken in 107 (87%) patients. The average number of antimicrobial agents used for empiric treatment was 1.7 (range 1-4). Treatment was altered on the basis of the Gram stain in 39 (36%) patients and altered again on culture results in 11 patients. Empiric treatment was altered on the basis of culture and sensitivity results alone in 42 (39%) of these 107 patients.
Of the 16 (13%) patients who were not treated empirically, treatment was started on the basis of the Gram stain in 13 (five of these were further changed on the basis of culture) and the remaining three patients had treatment started on the basis of culture results alone. There was complete compliance with therapeutic advice given by the microbiology team.
The appropriateness of empiric treatment was assessed in relation to the hospital antibiotic policy. Of 107 patients who received empiric treatment, 58 (54%) were in accordance with the antibiotic policy and 49 (46%) were not. These figures were broken down in relation to the underlying source of the bacteraemia (table 3) . Where treatment did not com- Of the 11 (9%) patients who died, 10 had received empiric treatment. In three (27%) of these patients death was caused by sepsis alone. In six (55%), death was due mainly to sepsis but there was a significant underlying illness, and in the remaining two (18%), death was due to an underlying illness alone. Patients who died were less likely to have received empiric treatment in accordance with the antibiotic policy then those who survived, but this did not reach statistical significance (p = 0.1). Seven patients died before Gram stain results were available.
Discussion
It has been suggested that the availability of broad spectrum antibiotics for empiric treatment should negate much of the clinical impact of a positive blood culture, particularly if it is felt that common blood culture isolates have predictable sensitivities.' This was not the case in our study. Despite the existence of a hospital antibiotic policy that guides empiric treatment, 26 (24%) of the 107 patients who received empiric treatment had an isolate that was resistant or had intermediate susceptibilities to the antibiotic(s) used.
The written policy was not adhered to in almost half of the patients studied. Specific infections, services, and classes of antibiotic were identified for future targeted education to improve policy compliance. In common with other hospitals, our policy is based on clinical determination of the likely source of infection to determine appropriate empiric treatment. That this procedure was not followed is demonstrated by the failure to consider the likelihood of Gram positive infection and the consequent excessive use of anti-Gram negative drugs. The failure to predict accurately likely pathogens in bacteriaemias has been demonstrated in a study by Spencely et 
